Fig. 4From: European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 updateForest plots of comparison: 2 Monoclonal antibodies vs placebo - Chronic migraineBack to article page